Onemednet Corp (ONMD) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Onemednet Corp (ONMD) stock forecast summary
On Oct. 14, 2026, ONMD is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
Onemednet Corp is a small-cap company with a market capitalization of $24M. It ranks number 10 by market capitalization among the 12 Services-Commercial Physical & Biological Research issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for ONMD is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.7% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ONMD included.
Follow ONMD freeONMD price chart and AI forecast
How ONMD ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Onemednet Corp (ONMD) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Commercial Physical & Biological Research peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | ONMD | Rank |
|---|---|---|
| Market Cap | $24M | 10/12 |
| EPS | $-0.10 | – |
Profitability & Margins
| Metric | ONMD | Rank |
|---|---|---|
| Gross Margin | -63.2% | 6/7 |
| Operating Margin | -875.3% | 11/13 |
| EBT Margin | -383.4% | 11/13 |
Financial Health
| Metric | ONMD | Rank |
|---|---|---|
| Current Ratio | 0.28x | 12/16 |
| Interest Coverage | -255.2x | 10/13 |
| Working Capital | -$3M | 11/15 |
Cash Flow
| Metric | ONMD | Rank |
|---|---|---|
| Operating Cash Flow | -$9M | 10/15 |
Income Statement
| Metric | ONMD | Rank |
|---|---|---|
| Operating Income | -$12M | 11/15 |
| R&D Expense | $2M | 5/7 |
| SG&A Expense | $14M | 8/12 |
| Cost of Goods Sold | $2M | 5/8 |
Dividend & Shareholder Information
| Metric | ONMD | Rank |
|---|---|---|
| Shares Outstanding | 6M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1M | |
| Cash & Short-term Investments | $360K | |
| Accounts Receivable | $660K | |
| Total Liabilities | $5M |
ONMD quarterly financials and insider trading
Onemednet Corp (ONMD) industry peers
Companies classified under the same SEC industry code as Onemednet Corp (Services-Commercial Physical & Biological Research): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| ONMD Onemednet Corp | ▶ | $24M |
| IQV Iqvia Holdings Inc. | ▼ | $43.51B |
| INCY Incyte Corp | ▼ | $21.70B |
| MEDP Medpace Holdings, Inc. | ▶ | $17.02B |
| CRL Charles River Laboratories International, Inc. | ▶ | $14.27B |
| ICLR Icon Plc | ▶ | $12.68B |
| ABSI Absci Corp | ▲ | $1.56B |
| OABI Omniab, Inc. | ▲ | $683M |
| NRC Nrc Health | ▲ | $446M |
| MXCT Maxcyte, Inc. | ▲ | $100M |
| VSBC Vitaspring Biomedical Co. Ltd. | ▼ | $7M |
| BUDZ Weed, Inc. | ▲ | $3M |
| BIAF Bioaffinity Technologies, Inc. | ▼ | N/A |
| CBIH Cannabis Bioscience International Holdings, Inc. | ▼ | N/A |
| FOXO Foxo Technologies Inc. | ▼ | N/A |
| ISPC Ispecimen Inc. | ▼ | N/A |
Where ONMD sits on the market map
Onemednet Corp (ONMD) stock news
Loading...
Onemednet Corp (ONMD) stock forecast FAQ
What is the Onemednet Corp (ONMD) stock forecast?
On Oct. 14, 2026, ONMD is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
How accurate are Onemednet Corp stock predictions?
A per-ticker accuracy statistic for ONMD is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Onemednet Corp forecasts updated?
Onemednet Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Onemednet Corp's industry peers?
16 issuers in our coverage, ONMD included, share the SEC industry code Services-Commercial Physical & Biological Research. The largest are: Iqvia Holdings Inc. (IQV), Incyte Corp (INCY), Medpace Holdings, Inc. (MEDP), Charles River Laboratories International, Inc. (CRL), Icon Plc (ICLR), Absci Corp (ABSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.